During the past decade, Cardiology Consultants conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology Consultants" #1 collaborator was "Medtronic" with 1 trials as a collaborator and "University of Rochester" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology Consultants" are "Cardiomyopathies" (1 trials), "Congestive Heart Failure" (1 trials), "Gender" (1 trials), "Heart Failure" (1 trials) and "Heart Failure, Congestive" (1 trials). Many other conditions were trialed in "Cardiology Consultants" in a lesser frequency.

Most popular intervention types in "Cardiology Consultants" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "MicroStent and Standard PTA" (1 trials), "Optimized interventricular delay biventricular pacing" (1 trials), "Protecta DR-ICD or CRT-D" (1 trials), "Protecta VR-ICD" (1 trials) and "Standard PTA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology Consultants" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Cardiology Consultants". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cardiology Consultants, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology Consultants, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".